|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Cyclic and individualized administration of gonadotropin-releasing hormone |
| agonists plus progestogens: an alternative protocol for contraception. |
| Chryssikopoulos A; Phocas I; Rizos D; Kontoravdis A |
| GYNECOLOGICAL ENDOCRINOLOGY. 1997 Apr;11(2):119-26. |
| 21 women presenting with different diseases, with absolute or relative contraindications to hormonal contraception or |
| the use of IUDs, received 300-600 mcg/day buserelin intranasally from the 1st to the 21st day, and 5 mg/day |
| norethisterone acetate orally from the 16th to the 23rd day of the cycle for a total of 245 cycles. Serum luteinizing |
| hormone (LH), follicle-stimulating hormone (FSH), estradiol and testosterone were determined on days 3-5 and 13-15 |
| of the cycle, while progesterone determinations and ovarian sonography were performed during the second half of the |
| cycle. According to progesterone values, 92.7% of the treatment cycles were anovulatory, while in one cycle |
| pregnancy was detected (0.4%). Values of serum LH, FSH, and estradiol were low, and in most of the cycles ovarian |
| follicular development was limited to follicles of 11 mm or less. In 21 treatment cycles (9%), statistically significant |
| increases in FSH (p < 0.0001) and LH (p < 0.02), as well as ovarian proliferation to preovulatory follicles or luteinized |
| follicles, were found. It appears that in spite of the high cost of medication and monitoring of patients, this regimen |
| could be useful as an alternative in cases where other forms of contraception are contraindicated or have failed. |
| (PubHealth.info Document ID: CONT2T 531-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Cyclic and individualized administration of gonadotropin- |
| releasing hormone agonists plus progestogens: an alternative protocol for contraception.", is(are) Chryssikopoulos |
| A; Phocas I; Rizos D; Kontoravdis A. The source of this article is "GYNECOLOGICAL ENDOCRINOLOGY. 1997 |
| Apr;11(2):119-26.". This article was published in 1997 in English language(s). (PubHealth.info® Document ID: |
| CONT2T 531-06. All rights reserved with PubHealth.info) PIN: 5531 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |